NHS prevents 17,000 strokes by hitting heart health target early

The NHS has hit a major public health target six years ahead of schedule. The achievement involves treating patients with atrial fibrillation, a condition that affects around 1.5 million people in England. More people are now receiving life-saving blood-thinning drugs as a result. Since January 2022, an additional 460,000 patients have begun taking anticoagulant medication. These drugs help treat and prevent blood clots in those with atrial fibrillation. Over 24 million prescriptions have been issued so far.

The programme has already prevented almost 17,000 strokes. It has also stopped an estimated 4,000 deaths. The NHS reports that 90% of high-risk AF patients now receive treatment.

The health service invested £45 million in its 'Detect, Protect, Perfect' initiatives. These aim to improve diagnosis and treatment for AF patients. The effort has also saved the NHS over £100 million in medicine costs. The rapid expansion of anticoagulant drug use has delivered clear benefits. Thousands of strokes and deaths have been avoided, and significant savings have been made. The NHS continues to push for wider access to these treatments.